CME Group Inc. (CME) stock

CMENasdaqSecurity & Commodity Brokers, Dealers, Exchanges & ServicesFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/3021% above fair value

$303.14+6.72 (+2.27%)

Close on Oct 30, 2026Market cap $109.00BP/E 25.7Yield 1.65%

Earnings

CME's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Feb 3, 2027

Q4 FY2026 · estimated, before the open

Revenue, Q3 FY2026

$1.70B

+10.6% on a year earlier

diluted earnings per common share, Q3 FY2026

$3.02

$2.68 a year earlier

Latest guidance

None

No outlook given in releases

Quarterly results

Revenue and earnings per share from each of CME's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q4 FY2026ended Dec 31, 2026	Feb 3, 2027Expected	–	–	–	–	–
Q3 FY2026ended Sep 30, 2026	Oct 21, 2026before the open	$1.70B	+10.6%	$2.89	$3.02	Release
Q2 FY2026ended Jun 30, 2026	Jul 22, 2026before the open	$1.70B	+0.5%	$2.88	$2.99	Release
Q1 FY2026ended Mar 31, 2026	Apr 22, 2026before the open	$1.90B	+18.8%	$3.18	$3.36	Release
Q4 FY2025ended Dec 31, 2025	Feb 4, 2026before the open	$1.60B	+6.7%	$3.24	$2.77	Release
Q3 FY2025ended Sep 30, 2025	Oct 22, 2025before the open	$1.54B	-3.9%	$2.49	$2.68	Release
Q2 FY2025ended Jun 30, 2025	Jul 23, 2025before the open	$1.69B	+12.8%	$2.81	$2.96	Release
Q1 FY2025ended Mar 31, 2025	Apr 23, 2025before the open	$1.60B	+6.7%	$2.62	$2.80	Release
Q4 FY2024ended Dec 31, 2024	Feb 12, 2025before the open	$1.50B	+7.1%	$2.40	$2.52	Release
Q3 FY2024ended Sep 30, 2024	Oct 23, 2024before the open	$1.60B	+23.1%	$2.50	$2.68	Release
Q2 FY2024ended Jun 30, 2024	Jul 24, 2024before the open	$1.50B	+7.1%	$2.42	$2.56	Release
Q1 FY2024ended Mar 31, 2024	Apr 24, 2024before the open	$1.50B	+7.1%	$2.35	$2.50	Release
Q4 FY2023ended Dec 31, 2023	Feb 14, 2024before the open	$1.40B	+16.7%	$2.24	$2.37	Release
Q3 FY2023ended Sep 30, 2023	Oct 25, 2023before the open	$1.30B	+8.3%	$2.06	$2.25	Release
Q2 FY2023ended Jun 30, 2023	Jul 26, 2023before the open	$1.40B	+16.7%	$2.14	$2.30	Release
Q1 FY2023ended Mar 31, 2023	Apr 26, 2023before the open	$1.40B	+7.7%	$2.43	$2.42	Release
Q4 FY2022ended Dec 31, 2022	Feb 8, 2023before the open	$1.20B	+9.1%	$1.75	$1.92	Release
Q3 FY2022ended Sep 30, 2022	Oct 26, 2022before the open	$1.20B	+9.1%	$1.87	$1.98	Release
Q2 FY2022ended Jun 30, 2022	Jul 27, 2022before the open	$1.20B	–	$1.82	$1.97	Release
Q1 FY2022ended Mar 31, 2022	Apr 27, 2022before the open	$1.30B	–	$1.95	$2.11	Release
Q4 FY2021ended Dec 31, 2021	Feb 9, 2022before the open	$1.10B	–	$1.71	$1.66	Release
Q3 FY2021ended Sep 30, 2021	Oct 27, 2021before the open	$1.10B	–	$2.58	$1.60	Release
Q2 FY2021ended Jun 30, 2021	Jul 28, 2021before the open	–	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	Apr 28, 2021before the open	–	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Feb 10, 2021before the open	–	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Oct 28, 2020before the open	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

CME has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When CME puts a forecast in an earnings release, it is listed here with the exact sentence.